Simplicity Wealth »

Karyopharm Therapeutics shares owned by Simplicity Wealth

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Simplicity Wealth from 13F filings

Historical chart of Simplicity Wealth investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Simplicity Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Simplicity Wealth

Quarter filed Position value Share count Share price at filing
2024-03-31 $67k 44k 1.51

More positions owned by Simplicity Wealth

Vanguard Index Fds Large Cap Etf (VV)
Sprott Physical Gold & Silve Tr Unit (CEF)
Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Sprott Physical Gold Tr Unit (PHYS)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Amazon (AMZN)

View all positions for Simplicity Wealth

Top funds holding Karyopharm Therapeutics

Vanguard Group
Avidity Partners Management
Palo Alto Investors
Citadel Advisors
Marshall Wace
Bnp Paribas Arbitrage, Snc
Millennium Management
CAM Group Holding A/S
Deutsche Bank Aktiengesellschaft
GSA Capital Partners
Goldman Sachs Group
Jpmorgan Chase & Co
AlphaCentric Advisors
Tejara Capital
Barclays

View all funds holding Karyopharm Therapeutics